Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Physiological Research
|
November 1, 2018
Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells
E Böhmová, D Machová, M Pechar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 12, 2002
Differences in the intracellular fate of free and polymer-bound doxorubicin
Ondrej Hovorka, M St'astný, T Etrych, et al.
Physiological Research
|
October 9, 2015
Nanotherapeutics shielded with a pH responsive polymeric layer
L Kostka, V Šubr, R Laga, et al.
Molecular Pharmaceutics
|
June 8, 2010
Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond
B Ríhová, T Etrych, M Sírová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 8, 2001
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
B Ríhová, T Etrych, M Pechar, et al.
Acta Biomaterialia
|
September 11, 2023
Adaptable polymerization platform for therapeutics with tunable biodegradability
M Hrochová, L Kotrchová, M Frejková, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 24, 2004
HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro
M Kovár, L Kovár, V Subr, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 29, 2008
New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting
P Chytil, T Etrych, C Konák, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 21, 2017
Polymer nitric oxide donors potentiate the treatment of experimental solid tumours by increasing drug accumulation in the tumour tissue
M Studenovsky, L Sivak, O Sedlacek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 20, 2022
Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis
A Libánská, E Randárová, S Skoroplyas, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Physiological Research
|
November 1, 2018
Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells
E Böhmová, D Machová, M Pechar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 12, 2002
Differences in the intracellular fate of free and polymer-bound doxorubicin
Ondrej Hovorka, M St'astný, T Etrych, et al.
Physiological Research
|
October 9, 2015
Nanotherapeutics shielded with a pH responsive polymeric layer
L Kostka, V Šubr, R Laga, et al.
Molecular Pharmaceutics
|
June 8, 2010
Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond
B Ríhová, T Etrych, M Sírová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 8, 2001
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
B Ríhová, T Etrych, M Pechar, et al.
Acta Biomaterialia
|
September 11, 2023
Adaptable polymerization platform for therapeutics with tunable biodegradability
M Hrochová, L Kotrchová, M Frejková, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 24, 2004
HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro
M Kovár, L Kovár, V Subr, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 29, 2008
New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting
P Chytil, T Etrych, C Konák, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 21, 2017
Polymer nitric oxide donors potentiate the treatment of experimental solid tumours by increasing drug accumulation in the tumour tissue
M Studenovsky, L Sivak, O Sedlacek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 20, 2022
Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis
A Libánská, E Randárová, S Skoroplyas, et al.
Page
of 4